Smoking has long been the biggest cause of cancer in the United States, but obesity, now the second leading cause, has been gaining ground. A new study from researchers at the University of Chicago finds that women with breast ...
May 7, 2019
0
9
A breast cancer cell is like a house with three locks on the front door. Keys, or receptors, allow drugs to unlock the door and kill the cell. However, in triple-negative breast cancer, these keys are absent, thereby resulting ...
Apr 17, 2019
0
8
Weill Cornell Medicine researchers have shown that giving mice with triple-negative breast cancer therapeutic microRNA (miRNA) in a protective gold nanoparticle results in significantly less spreading of cancer to the lung. ...
Apr 12, 2019
0
5
The type of breast cancer most likely to affect young people and African Americans is also one of the most aggressive and difficult to treat.
Apr 3, 2019
0
75
Of the three major subtypes of breast cancer, triple negative is the most lethal. Half of all breast cancer deaths are attributed to it, whereas it accounts for only about 15 percent of incidences of breast cancer. And unlike ...
Mar 29, 2019
0
6
It has long been thought that stress contributes to cancer progression. Scientists from the University of Basel and the University Hospital of Basel have deciphered the molecular mechanisms linking breast cancer metastasis ...
Mar 14, 2019
0
3053
The genetic and molecular make-up of individual breast tumours holds clues to how a woman's disease could progress, including the likelihood of it coming back after treatment, and in what time frame, according to a Cancer ...
Mar 13, 2019
0
15
RNA transcribed from genes that seem not to code for anything may play an important role in regulating cancer, a new study suggests.
Mar 13, 2019
0
5
Two University of Delaware researchers have developed a new approach to attack cancer, using two light-activated treatments that appear to be more effective together than when applied independently. More research is needed, ...
Mar 12, 2019
0
628
(HealthDay)—The U.S. Food and Drug Administration has given its blessing to the first immunotherapy regimen for breast cancer.
Mar 12, 2019
0
54
